-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - Bisphosphonates are a group of medicines used to treat osteopenia or
osteoporosis, which are conditions
-
cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
July 18, 2023 - Bisphosphonates are a group of medicines used to treat osteopenia or
osteoporosis, which are conditions
-
cds.ahrq.gov/taxonomy/term/30781
July 30, 2021 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-09/Wells%20Criteria.txt
January 01, 2023 - Wells Criteria - Derivation of a simple clinical model to categorize patientsÕ probability of pulmonary embolism.
Rules
1. IF [Wells score >4] THEN [CTPE]
2. IF [Wells Score <=4] AND [D-dimer normal] THEN NOT [CTPE]
3. IF [Wells score <=4] AND [D-Dimer elevated] THEN [CTPE]
Additional Values (Wells score)
- Clinical…
-
cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
02/08/2017
Time
1:30 – 3:30 PM ET
AGENDA
· Welcome
· Discuss Remaining Repository Questions
· Clarify 10-Year Risk Assessment Details
· Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact
· Discuss Next Artifacts for Developmen…
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - For a discussion of how employers should treat
situations in which an employee may be covered both … This can be exacerbated by obesity and medications use to treat diabetes and its
complications. … The medications
used to treat the both the disease and its complications can also cause difficulty … Perform regular glucose measurements and know how and when to treat
hypoglycemia (low blood glucose … Patient Guidance
Perform regular glucose measurements and know how and when to treat
hypoglycemia
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…
-
cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
January 01, 2016 - Cholesterol Management Work Group
Meeting Summary
Date
12/09/16
Time
2:00 – 4:00 PM EST
AGENDA
· Welcome and Introductions
· CDS Connect Project Overview
· CDS Cholesterol Management Work Group Overview and Planning
· CDS Cholesterol Management Environmental Scan Findings and Artifacts
· CDS Cho…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - This includes identifying expectations, setting goals to treat medical
problems and reach best health … Inclusion,
Intervention
“medication” A drug or other substance used to treat disease or injury; a … analgesic
medication”
Medications with at least one active ingredient that is primarily used to treat … non pain” condition
but can be used either alone or with other analgesics (opioid or nonopioid) to treat … Intervention “Nonpharmacologic
treatments”
Nonmedication procedures and therapies employed to treat
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Shared
Decision Making
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ah…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk (April 2021)
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Updated 10-
Year ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD…
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ)
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document.
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared for:
Agency for Healthcare Re…
-
cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
01/11/2017
Time
3:00 – 5:00 PM ET
AGENDA
· Welcome and introductions
· Discuss ACC/AHA 10-Year ASCVD Risk Assessment Tool Metadata and CDS creation
· Discuss Longitudinal Risk Assessment Tool Metadata, CDS Creation and Shared Decision Making
· Questions to…
-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
April 21, 2022
3:00 – 4:00 pm ET
Attendees: 31 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3)
WG Members Alex Go…
-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_WG_February_2022_Summary.pdf
January 01, 2022 - CDS Connect Work Group February 2022 Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
February 17, 2022
3:00 – 4:00 pm ET
Attendees: 37 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Mario Teran, Roland Gamache (2)
WG Members Alex Goel, Alison…
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal ASCVD
Risk Assessment Tool for Baseline 10-Year
ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857 …
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Baseline 10-
Year ASCVD Risk
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
October 28, 2021 - problem list item 1 LTRA Rule 4 recommendation given yes no assume is addition, is not a Step 4 therapy, treat … problem list item 1 LTRA Rule 4 recommendation given no yes assume is addition, is not a Step 4 therapy, treat … active, confirmed problem list item 3 LTRA (montelukast) Rule 6a (D) recommendation given yes no would treat
-
cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
October 28, 2021 - problem list item 1 LTRA Rule 4 recommendation given yes no assume is addition, is not a Step 4 therapy, treat … problem list item 1 LTRA Rule 4 recommendation given no yes assume is addition, is not a Step 4 therapy, treat … active, confirmed problem list item 3 LTRA (montelukast) Rule 6a (D) recommendation given yes no would treat